What is the treatment for a glutathione (GSH) oral overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Glutathione Oral Overdose Management

Glutathione oral overdose does not require specific treatment because oral glutathione has negligible systemic bioavailability and is not absorbed intact from the gastrointestinal tract. 1

Why No Treatment is Necessary

Oral glutathione is essentially non-toxic due to poor absorption:

  • A clinical study in healthy volunteers demonstrated that even after administration of 3 grams of oral glutathione (0.15 mmol/kg), plasma glutathione concentrations did not increase significantly over 270 minutes 1
  • The systemic availability of oral glutathione is negligible in humans because intestinal and hepatic gamma-glutamyltransferase rapidly hydrolyze glutathione before it reaches systemic circulation 1
  • Dietary glutathione is not a major determinant of circulating glutathione levels, making it impossible to increase circulating glutathione to clinically significant levels through oral administration 1

Supportive Care Only

If a patient presents after ingesting large amounts of oral glutathione, provide only supportive care:

  • Monitor for gastrointestinal symptoms (nausea, vomiting, abdominal discomfort) which would be the only expected effects from large oral doses 1
  • No specific antidote or decontamination procedures are indicated 1
  • Reassure the patient that systemic toxicity is not expected due to the lack of absorption 1

Important Distinction from Intravenous Glutathione

This guidance applies only to oral overdose - intravenous glutathione has different pharmacokinetics:

  • Intravenous glutathione bypasses first-pass metabolism and achieves therapeutic blood levels 2
  • Clinical trials using intravenous glutathione at doses of 1,500-5,000 mg have been conducted safely in cancer patients receiving chemotherapy 3
  • However, these studies involved controlled medical administration, not overdose scenarios 3

Clinical Context

Glutathione's poor oral bioavailability is well-established:

  • Absorption from the gastrointestinal tract is so poor that high oral doses (up to 3 grams) fail to achieve therapeutic effects 1, 2
  • Alternative routes such as orobuccal absorption using specialized delivery systems have been developed specifically because oral absorption is inadequate 2

References

Research

The systemic availability of oral glutathione.

European journal of clinical pharmacology, 1992

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.